Kearns & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Kearns & Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$474K	Hold	946	–	–	0.22%	29
2026 Q1	$465K	Hold	946	–	–	0.25%	28
2025 Q4	$548K	Sell	946 -72	-7%	-$40.7K	0.28%	28
2025 Q3	$494K	Sell	1,018 -115	-10%	-$53.5K	0.26%	30
2025 Q2	$459K	Sell	1,133 -32	-3%	-$13.4K	0.26%	32
2025 Q1	$580K	Sell	1,165 -195	-14%	-$106K	0.38%	24
2024 Q4	$708K	Hold	1,360	–	–	0.46%	19
2024 Q3	$841K	Sell	1,360 -20	-1%	-$11.8K	0.55%	13
2024 Q2	$763K	Sell	1,380 -20	-1%	-$11.5K	0.57%	16
2024 Q1	$814K	Hold	1,400	–	–	0.63%	12
2023 Q4	$743K	Hold	1,400	–	–	0.63%	11
2023 Q3	$709K	Hold	1,400	–	–	0.67%	11
2023 Q2	$730K	Hold	1,400	–	–	0.66%	11
2023 Q1	$807K	Hold	1,400	–	–	0.8%	10
2022 Q4	$771K	Buy	+1,400	New	+$742K	0.81%	10

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Kearns & Associates's TMO Position: Q2 2026 in Review

Kearns & Associates held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 946 shares worth $474K. The position accounts for 0.22% of the portfolio, ranked #29.

Kearns & Associates first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $841K in Q3 2024. 1,066 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Kearns & Associates held 946 shares of Thermo Fisher Scientific worth $474K as of Q2 2026.
Kearns & Associates left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.22% of Kearns & Associates's portfolio in Q2 2026, its #29 holding.
Kearns & Associates first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
Kearns & Associates's Thermo Fisher Scientific position peaked at $841K in Q3 2024.
1,066 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Kearns & Associates's 13F filing for Q2 2026, filed 23 Jul 2026.